Michael McLay, MD
Family Medicine · Springville, UTNPI 1063605475
Payments from drug & device makers
Across 28 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114
- GSK$59
- Novo Nordisk$57
- Boehringer Ingelheim$43
- Axsome Therapeutics, Inc.$32
- Sanofi-aventis U.S. LLC$25
- plus $143 from 10 others
What the payments were for
- Food & beverage$474100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 5 | $114 |
| GSK | 3 | $59 |
| Novo Nordisk | 4 | $57 |
| Boehringer Ingelheim | 3 | $43 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Strongbridge US Inc. | 1 | $18 |
| Medtronic | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| AstraZeneca | 1 | $13 |
| Organon | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$474 in reported general payments places this provider in the 50th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 97 | $2,908 |
| Atorvastatin Calcium | 97 | $1,052 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $861 |
| Doxycycline Monohydrate | 46 | $720 |
| Levothyroxine Sodium | 66 | $613 |
| Lisinopril | 50 | $557 |
| Fluoxetine Hcl | 20 | $541 |
| Meloxicam | 53 | $523 |
| Buspirone Hcl | 22 | $521 |
| Trazodone Hcl | 48 | $503 |
| Simvastatin | 42 | $489 |
| Zolpidem Tartrate | 63 | $466 |
| Tamsulosin Hcl | 34 | $461 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $445 |
| Amlodipine Besylate | 54 | $437 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Springville
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
- Sarang YoonSalt Lake City$9.4M
- Michael AdamsSandy$8.1M
- Katie JulienSouth Jordan$7.1M
- Scott EricksonBountiful$3.7M
- John RichardsSouth Jordan$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.